| Product Code: ETC7641936 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of thalidomide to Ireland in 2024 show a notable shift in concentration, with top exporting countries being Switzerland, Belgium, USA, UK, and China. The Herfindahl-Hirschman Index (HHI) indicates a significant decrease in concentration from 2023 to 2024. Despite a high compound annual growth rate (CAGR) of 11.32% from 2020 to 2024, there was a sharp decline in growth rate (-47.44%) from 2023 to 2024. This suggests a changing landscape in the thalidomide import market in Ireland, reflecting fluctuations in supply sources and demand dynamics.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Thalidomide Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Thalidomide Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Thalidomide Market - Industry Life Cycle |
3.4 Ireland Thalidomide Market - Porter's Five Forces |
3.5 Ireland Thalidomide Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Ireland Thalidomide Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Ireland Thalidomide Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diseases like multiple myeloma and leprosy that require thalidomide treatment |
4.2.2 Growing aging population in Ireland leading to higher demand for thalidomide for various conditions |
4.2.3 Advancements in healthcare infrastructure and access to treatment options driving the usage of thalidomide |
4.3 Market Restraints |
4.3.1 Stringent regulations and monitoring due to historical thalidomide-related incidents leading to limited availability and distribution |
4.3.2 Potential side effects and risks associated with thalidomide leading to concerns among healthcare professionals and patients |
5 Ireland Thalidomide Market Trends |
6 Ireland Thalidomide Market, By Types |
6.1 Ireland Thalidomide Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Thalidomide Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Ireland Thalidomide Market Revenues & Volume, By Purity98%, 2021- 2031F |
6.1.4 Ireland Thalidomide Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Ireland Thalidomide Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Ireland Thalidomide Market Revenues & Volume, By Leprosy, 2021- 2031F |
6.2.3 Ireland Thalidomide Market Revenues & Volume, By Arthropathy, 2021- 2031F |
7 Ireland Thalidomide Market Import-Export Trade Statistics |
7.1 Ireland Thalidomide Market Export to Major Countries |
7.2 Ireland Thalidomide Market Imports from Major Countries |
8 Ireland Thalidomide Market Key Performance Indicators |
8.1 Number of new clinical trials or research studies involving thalidomide in Ireland |
8.2 Percentage increase in prescriptions for thalidomide over a specific period |
8.3 Patient adherence rate to thalidomide treatment protocols |
8.4 Rate of adverse events reported related to thalidomide usage |
8.5 Number of healthcare facilities offering thalidomide treatment in Ireland |
9 Ireland Thalidomide Market - Opportunity Assessment |
9.1 Ireland Thalidomide Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Ireland Thalidomide Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Ireland Thalidomide Market - Competitive Landscape |
10.1 Ireland Thalidomide Market Revenue Share, By Companies, 2024 |
10.2 Ireland Thalidomide Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here